Olympic Ophthalmics

Curated by Signal

Provider and developer of tear production device for treatments of dry eye disease

Overview

Provider and developer of tear production device for treatments of dry eye disease. The company has developed iTEAR 100 a medical device technology that has the ability to stimulate tear production in an individual using neurostimulation methodology. It also has an app that can be used by doctors and patients to share medical documents, prescription data, and track health.

Key facts

Founded: 2020
Headquarters: Issaquah, United States
Stage: Sign up to view
Industry: Health Technology

Business model

4 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

AbleTo
Offers a digital platform to connect people with licensed therapists and coaches
Health TechnologyNew York City, United States
Oliver's Harvest
Provider of medicinal cannabis products
Health TechnologyWellington, United States
DRGcheck
Cloud-based platform to find coding, compliance and financial risks
Health TechnologySaint Paul, United States

About Olympic Ophthalmics

What does Olympic Ophthalmics do?

Provider and developer of tear production device for treatments of dry eye disease.

Where is Olympic Ophthalmics headquartered?

Olympic Ophthalmics is headquartered in Issaquah, United States.

When was Olympic Ophthalmics founded?

Olympic Ophthalmics was founded in 2020.

Which sector is Olympic Ophthalmics in?

Olympic Ophthalmics operates in Health Technology.

Who are Olympic Ophthalmics's competitors?

Companies similar to Olympic Ophthalmics include AbleTo, Oliver's Harvest, and DRGcheck.